About Medicure
Medicure is a publicly listed company based in Winnipeg (Canada) founded in 1997 by Albert D Friesen. Affordable therapeutics are developed and e-commerce pharmacy services are provided. The company has 23 employees. Medicure has completed 2 acquisitions, including Apicore and Marley Drug. Its chief executive, as recorded, is Albert D Friesen. Its website medicure.com draws about 11 thousand monthly visits. Its Indian entity Medicure Solutions India Private Limited reported revenue of ₹5.04 Cr. Medicure offers products and services including AGGRASTAT and Zypitamag. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.
Company details
Medicure was founded in 1997 in Winnipeg, Canada, within the pharmaceutical sector. Innovative and affordable medications are developed and commercialized by the company. An online pharmacy platform is operated to fulfill prescriptions and deliver a range of medications. Products are marketed to healthcare professionals and consumers via e-commerce channels. Operations center on therapeutics development and prescription services in Canada.
- Headquarters Winnipeg, Canada
- Employees 23
- Founders Albert D Friesen
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website medicure.com
- Social LinkedIn
- Legal Name Medicure Inc.
- Indian entity revenue₹5.04 Cr
FY 2024 · +139% YoY
- Indian entity net profit₹3.7 Lakh
FY 2024 · 1% margin
- Indian entity EBITDA₹5.1 Lakh
FY 2024 · 1% margin
- Latest Funding Round$44.65M (USD), Debt – Conventional
Nov 2016
- InvestorsCrown Capital Partners
& 1 more
- Employee Count23
- Investments & AcquisitionsApicore
& 1 more
Associated legal entities of Medicure
Medicure operates through Medicure Solutions India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medicure Solutions India Private Limited CIN U33203DL2021PTC389500 | Active | 08 Nov 2021 | Delhi, Delhi | ₹5.0 Cr | 2 | View details |
Products & Services of Medicure
Medicure offers a comprehensive portfolio of products and services, including AGGRASTAT and Zypitamag.
AGGRASTAT is provided as a therapeutic injection for cardiovascular conditions, contributing to patient care through its commercialization.
Zypitamag is offered as a medication within the growing portfolio, aimed at addressing health needs in the U.S. market.
Funding Insights of Medicure
- Total Rounds 3
- Last Round Debt – Conventional — $44.65M
- Investors Count 2
All 3 funding rounds of Medicure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2016 | $44.65M | Debt – Conventional | – | – | |
| Jun 2015 | $3.04M | Post-IPO | – | – | – |
| Apr 2005 | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in Medicure
Medicure has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Crown Capital Partners and CentreStone Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A venture capital fund focused on life sciences is operated. | centrestoneventures.com | Winnipeg, Canada | ||
Distributed power and broadband network solutions are developed. | 2000 | crowncapital.ca | Toronto, Canada |
Investor details for Medicure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Medicure Solutions India Private Limited (Medicure)
Medicure Solutions India Private Limited is the primary company behind Medicure. The board of Medicure Solutions India Private Limited currently have 2 directors; the longest-serving is Lalit Malik, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lalit Malik DIN 05149122 | Director | 08 Nov 2021 | 5 yrs | Medicure Solutions India Private Limited |
| Neena Grover DIN 01131791 | Director | 08 Nov 2021 | 5 yrs | Medicure Solutions India Private Limited |
People of Medicure
11 people are tracked at Medicure (5 in leadership, 6 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Albert D Friesen | Founder and CEO | Leadership |
Vanessa Ruys | Director Of Pharmacy Operations | Leadership |
Haaris Uddin | Chief Financial Officer | Leadership |
Scott Dyck | Marketing Director | Leadership |
Neil Owens | President & COO | Leadership |
Jung-Ae Park | Marketing Specialist | Team |
Mina Ghaies | Financial Analyst | Team |
Rina Donnelly | Office Coordinator | Team |
Lauren Kressock | National Sales Manager | Team |
Bonita Reimer | Marketing Assistant | Team |
Tenzin Yewang (CCRA®) | Project Coordinator | Team |
Complete people profiles for Medicure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Medicure
Medicure is a publicly listed company on the TSXV with ticker symbol MPH in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Mar 2010
- Listed onTSX-V: MPH
- Listed entityMedicure Inc.
- Exchange sectorHealth technology
- ISINCA58469E4085
- Share price3.70 CAD (+24.16% on the day) · 2026-10-13
- Market capitalisation38,614,361.00 CAD
- EPS (diluted, trailing year)-0.71 CAD
- Volume (last session)11,192
Financials of Medicure
Figures of Medicure Solutions India Private Limited, the primary company behind Medicure, for FY 2024. Revenue was ₹5.04 Cr (+139% year on year). Net profit was ₹3.7 Lakh (1% margin). EBITDA was ₹5.1 Lakh (1% margin).
- ₹5.04 CrRevenue · FY 2024 · +139% YoY
- ₹3.7 LakhNet profit · 1% margin
- ₹5.1 LakhEBITDA · 1% margin
- ₹15 LakhPaid-up capital
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 28.9M CAD | -7.1M CAD | -4.2M CAD |
| 2024 | 21.9M CAD | -1.0M CAD | -423,000 CAD |
| 2023 | 21.7M CAD | -922,000 CAD | 1.3M CAD |
| 2022 | 23.1M CAD | 1.4M CAD | 3.2M CAD |
| 2021 | 21.7M CAD | -727,000 CAD | 1.1M CAD |
Balance sheet, profit and loss, cash flow and ratios of Medicure Solutions India Private Limited are on its company page.
Detailed financial statements for Medicure
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medicure
Medicure has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Apicore and Marley Drug.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Supplier of pharmaceutical products | marleydrug.com | Winston-salem, United States | 2003 | Dec 2020 | •••• | |
APIs are manufactured and custom synthesis services are provided. | apicore.com | Somerset, United States | 2004 | Jul 2017 | $50M |
Complete acquisition details for Medicure
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Medicure
6 dated milestones of Medicure across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Medicure is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Debt – Conventional, of $44.6M.
- Acquisition Acquires Apicore.
- Acquisition Acquires Marley Drug.
Web traffic of Medicure
The website of Medicure (medicure.com) receives about 11.4K visits a month and ranks #2,342,640 among all websites worldwide, #3,199 in Biotechnology and Pharmaceuticals.
- Monthly visits11.4K
▲ 22.4% vs previous month
- Unique visitors3.9K
per month
- Global rank#2,342,640
among all websites
- Category rank#3,199
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit1.8
- Average visit35 sec
- DevicesDesktop 28% · Mobile 72%
Websites whose visitors overlap most with Medicure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| scdm.org | 100% | #2,035,255 | View details | ||
| ifpma.org | 99% | #875,178 | View details | ||
| pharmacyclics.com | 98% | 3.1K | #5,482,945 | View details | |
| fda.gov | 68% | #7,606 | View details | ||
| rxlist.com | 68% | 773.1K | #74,626 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Medicure
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medicure
Complete news archive for Medicure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicure
Medicure was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Medicure is headquartered in Winnipeg, Canada. It is registered at Winnipeg, Manitoba, Canada.
Albert D Friesen is the CEO of Medicure, as recorded in our data. They have also founded this company.
Medicure has 23 employees.
The primary company behind Medicure, Medicure Solutions India Private Limited, reported revenue of ₹5.04 Cr for FY 2024, up 139% year on year.
Medicure was founded in 1997 in Winnipeg, Canada, within the pharmaceutical sector. Innovative and affordable medications are developed and commercialized by the company. An online pharmacy platform is operated to fulfill prescriptions and deliver a range of medications. Products are marketed to healthcare professionals and consumers via e-commerce channels. Operations center on therapeutics development and prescription services in Canada.
Medicure offers AGGRASTAT and Zypitamag.
Yes, Medicure is publicly traded on TSXV under the ticker symbol MPH.
Medicure has made 2 acquisitions, including Apicore, and Marley Drug.
Medicure has 2 investors. Key investors include Crown Capital Partners, and CentreStone Ventures.
Medicure operates through Medicure Solutions India Private Limited.
The legal entities of Medicure currently have 2 directors, including Lalit Malik, Neena Grover.